Cell stress proteins: Novel immunotherapeutics

Novartis Foundation Symposium

Volumn 291, Issue , 2008, Pages 115-131

  Calderwood, Stuart K ^a   Gong, Jianlin ^a   Theriault, Jimmy R ^a   Mambula, Salamatu S ^a   Gray Jr , Philip J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; EXTRACELLULAR SPACE; HUMAN; IMMUNOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX; METABOLISM; NEOPLASM;

ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; CANCER VACCINES; EXTRACELLULAR SPACE; HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; NEOPLASMS;

EID: 52449109796     PISSN: 15282511     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (102)

1. Agarraberes FA, Terlecky SR, Dice JF 1997 An intralysosomal hsp70 is required for a selective pathway of lysosomal protein degradation. J Cell Biol 137:825-834
2. Arnold-Schild D, Hanau D, Spehner D et al 1999 Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells. J Immunol 162:3757-3760
3. Asea A, Kabingu E, Stevenson MA, Calderwood SK 2000a HSP70 peptide-bearing preparations act as chaperokines. Cell Stress Chaperones 5:425-431
4. Asea A, Kraeft SK, Kurt-Jones EA et al 2000b HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med 6:435-442
5. Asea A, Rehli M, Kabingu E et al 2002 Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 277:15028-15034
6. Baker-LePain JC, Reed RC, Nicchitta CV 2003 ISO: a critical evaluation of the role of peptides in heat shock/chaperone protein-mediated tumor rejection. Curr Opin Immunol 15:89-94
7. Becker T, Hartl FU, Wieland F 2002 CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes. J Cell Biol 158:1277-1285
8. Belli F, Testori A, Rivoltini L et al 2002 Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings. J Clin Oncol 20:4169-4180
9. Berwin B, Nicchitta CV 2001 To find the road traveled to tumor immunity: the trafficking itineraries of molecular chaperones in antigen-presenting cells. Traffic 2:690-697
10. Binder RJ, Srivastava PK 2005 Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cells. Nat Immunol 6:593-599
11. Binder RJ, Han DK, Srivastava PK 2000 CD91: a receptor for heat shock protein gp96. Nat Immunol 1:151-155
12. Bukau B, Horwich AL 1998 The Hsp70 and Hsp60 chaperone machines. Cell 92:351-66
13. Bukau B, Weissman J, Horwich A 2006 Molecular chaperones and protein quality control. Cell 125:443-451
14. Calderwood SK 2005 Chaperones and slow death - a recipe for tumor immunotherapy. Trends Biotechnol 23:57-59
15. Calderwood SK, Theriault JR, Gong J 2005 Message in a bottle: role of the 70-kDa heat shock protein family in anti-tumor immunity. Eur J Immunol 35:2518-2527
16. Calderwood SK, Khaleque MA, Sawyer DB, Ciocca DR 2006 Heat shock proteins: chaperones of tumorigenesis. Trends Biochem Sci 31:164-172
17. Calderwood SK, Khaleque MA, Ciocca DR 2007 Heat shock proteins in the progression of cancer, Vol. 7. Springer, New York
18. Chandawarkar RY, Wagh MS, Srivastava PK 1999 The dual nature of specific immunological activity of tumor-derived gp96 preparations. J Exp Med 189:1437-1442
19. Chen Q, Fisher DT, Clancy KA et al 2006 Fever-range thermal stress promotes lymphocyte trafficking across high endothelial venules via an interleukin 6 trans-signaling mechanism. Nat Immunol 12:1299-1308
20. Chiang HL, Terlecky SR, Plant CP, Dice JF 1989 A role for a 70-kilodalton heat shock protein in lysosomal degradation of intracellular proteins. Science 246:382-385
21. Chouaib S, Thiery J, Gati A et al 2002 Tumor escape from killing: role of killer inhibitory receptors and acquisition of tumor resistance to cell death. Tissue Antigens 60:273-281
22. Ciocca DR, Calderwood SK 2005 Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment applications. Cell Stress Chaperones 10:86-103
23. Clark PR, Menoret A 2001 The inducible Hsp70 as a marker of tumor immunogenicity. Cell Stress Chaperones 6:121-125
24. Cohen-Sfady M, Nussbaum G, Pevsner-Fischer M et al 2005 Heat shock protein 60 activates B cells via the TLR4-MyD88 pathway. J Immunol 175:3594-3602
25. Cominacini L, Pasini AF, Garbin U et al 2000 Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem 275:12633-12638
26. Cornford PA, Dodson AR, Parsons KF et al 2000 Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res 60:7099-7105
27. Cuervo AM, Dice JF 1998 Lysosomes, a meeting point of proteins, chaperones, and proteases. J Mol Med 76:6-12
28. Daniels GA, Sanchez-Perez L, Diaz RM et al 2004 A simple method to cure established tumors by inflammatory killing of normal cells. Nat Biotechnol 22:1125-1132
29. Delneste Y, Magistrelli G, Gauchat J et al 2002 Involvement of LOX-1 in dendritic cellmediated antigen cross-presentation. Immunity 17:353-362
30. Engelhard VH, Bullock TN, Colella TA, Sheasley SL, Mullins DW 2002 Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy. Immunol Rev 188:136-146
31. Engleman EG, Brody J, Soares L 2004 Using signaling pathways to overcome immune tolerance to tumors. Sci STKE pe28
32. Enomoto Y, Bharti A, Khaleque AA et al 2006 Enhanced immunogenicity of heat shock protein 70 peptide complexes from dendritic cell-tumor fusion cells. J Immunol 177:5946-5955
33. Evans SS, Wang WC, Bain MD, Burd R, Ostberg JR, Repasky EA 2001 Fever-range hyperthermia dynamically regulates lymphocyte delivery to high endothelial venules. Blood 97:2727-2733
34. Flaherty KM, DeLuca-Flaherty C, McKay DB 1990 Three-dimensional structure of the ATPase fragment of a 70K heat-shock cognate protein. Nature 346:623-628
35. Floto RA, MacAry PA, Boname JM et al 2006 Dendritic cell stimulation by mycobacterial Hsp70 is mediated through CCR5. Science 314:454-458
36. Flynn GC, Chappell TG, Rothman JE 1989 Peptide binding and release by proteins implicated as catalysts of protein assembly. Science 245:385-390
37. Fourie AM, Sambrook JF, Gething MJ 1994 Common and divergent peptide binding specificities of hsp70 molecular chaperones. J Biol Chem 269:30470-30478
38. Gao B, Tsan MF 2003 Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor alpha release by murine macrophages. J Biol Chem 278:174-179
39. Georgopolis C, Welch WJ 1993 Role of the major heat shock proteins as molecular chaperones. Annu Rev Cell Biol 9:601-634
40. Germain RN 1994 MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76:287-299
41. Goldberg AL, Cascio P, Saric T, Rock KL 2002 The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides. Mol Immunol 39:147-164
42. Gragerov A, Gottesman ME 1994 Different peptide binding specificities of hsp70 family members. J Mol Biol 241:133-135
43. Gromme M, Neefjes J 2002 Antigen degradation or presentation by MHC class I molecules via classical and non-classical pathways. Mol Immunol 39:181-202
44. Grossmann ME, Madden BJ, Gao F et al 2004 Proteomics shows Hsp70 does not bind peptide sequences indiscriminately in vivo. Exp Cell Res 297:108-117
45. Hasan A, Sadoh D, Palmer R, Foo M, Marber M, Lehner T 2005 The immune responses to human and microbial heat shock proteins in periodontal disease with and without coronary heart disease. Clin Exp Immunol 142:585-594
46. Huang XF, Ren W, Rollins L et al 2003 A broadly applicable, personalized heat shock proteinmediated oncolytic tumor vaccine. Cancer Res 63:7321-7329
47. Jeannin P, Bottazzi B, Sironi M et al 2005 Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors. Immunity 22:551-560
48. Larsson M, Fonteneau JF, Bhardwaj N 2001 Dendritic cells resurrect antigens from dead cells. Trends Immunol 22:141-148
49. Li D, Liu L, Chen H, Sawamura T, Mehta JL 2003 LOX-1, an oxidized LDL endothelial receptor, induces CD40/CD40L signaling in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol 23:816-821
50. Lindquist S, Craig EA 1988 The heat shock proteins. Annu Rev Genet 22:631-637
51. Mambula SS, Calderwood SK 2006a Heat induced release of Hsp70 from prostate carcinoma cells involves both active secretion and passive release from necrotic cells. Int J Hyperthermia 22:575-585
52. Mambula SS, Calderwood SK 2006b Heat shock protein 70 is secreted from tumor cells by a nonclassical pathway involving lysosomal endosomes. J Immunol 177:7849-7857
53. Manjili MH, Wang XY, Chen X et al 2003 HSP110-HER2/neu chaperone complex vaccine induces protective immunity against spontaneous mammary tumors in HER-2/neu transgenic mice. J Immunol 171:4054-4061
54. Mazzaferro V, Coppa J, Carrabba MG et al 2003 Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancer. Clin Cancer Res 9:3235-3245
55. Melcher A, Todryk S, Hardwick N, Ford M, Jacobson M, Vile RG 1998 Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat Med 4:581-587
56. Millar DG, Garza KM, Odermatt B et al 2003 Hsp70 promotes antigen-presenting cell function and converts T-cell tolerance to autoimmunity in vivo. Nat Med 9:1469-1476
57. Moller P, Hammerling G 1992 The role of surface HLA A, B, C molecules in tumor immunity. Cancer Surv 13:101-127
58. Monaco JJ 1992 A molecular model of MHC class-I-restricted antigen processing. Immunol Today 13:173-179
59. Multhoff G 2002 Activation of natural killer cells by heat shock protein 70. Int J Hyperthermia 18:576-585
60. Multhoff G, Hightower LE 1996 Cell surface expression of heat shock proteins and the immune response. Cell Stress Chaperones 1:167-176
61. Nadler SG, Tepper MA, Schacter B, Mazzucco CE 1992 Interaction of the immunosuppressant deoxyspergualin with a member of the Hsp70 family of heat shock proteins. Science 258:484-486
62. Neefjes JJ, Momburg F, Hammerling GJ 1993 Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science 261:769-771
63. Noessner E, Gastpar R, Milani V et al 2002 Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells. J Immunol 169:5424-5432
64. Nylandsted J, Brand K, Jaattela M 2000 Heat shock protein 70 is required for the survival of cancer cells. Ann N Y Acad Sci 926:122-125
65. Ohashi PS, DeFranco AL 2002 Making and breaking tolerance. Curr Opin Immunol 14:744-759
66. Ouaaz F, Arron J, Zheng Y, Choi Y, Beg AA 2002 Dendritic cell development and survival require distinct NF-kappaB subunits. Immunity 16:257-270
67. Panjwani N, Akbari O, Garcia S, Brazil M, Stockinger B 1999 The HSC73 molecular chaperone: involvement in MHC class II antigen presentation. J Immunol 163:1936-1942
68. Pardoll D 2003 Does the immune system see tumors as foreign or self? Annu Rev Immunol 21:807-839
69. Pockley AG 2003 Heat shock proteins as regulators of the immune response. Lancet 362:469-476
70. Pulendran B 2004 Modulating vaccine responses with dendritic cells and Toll-like receptors. Immunol Rev 199:227-250
71. Quintana FJ, Cohen IR 2005 Heat shock proteins regulate inflammation by both molecular and network cross-reactivity. Cambridge University Press, Cambridge
72. Quintana FJ, Carmi P, Mor F, Cohen IR 2004 Inhibition of adjuvant-induced arthritis by DNA vaccination with the 70-kd or the 90-kd human heat-shock protein: immune cross-regulation with the 60-kd heat-shock protein. Arthritis Rheum 50:3712-3720
73. Repasky E, Issels R 2002 Physiological consequences of hyperthermia: heat, heat shock proteins and the immune response. Int J Hyperthermia 18:486-489
74. Rock KL, York IA, Saric T, Goldberg AL 2002 Protein degradation and the generation of MHC class I-presented peptides. Adv Immunol 80:1-70
75. Rock KL, Hearn A, Chen CJ, Shi Y 2005 Natural endogenous adjuvants. Springer Semin Immunopathol 26:231-246
76. Rosenberg SA 2004 Shedding light on tumor immunotherapy of cancer. N Engl J Med 350:1461-1463
77. Rosenberg SA, Yang JC, Restifo NP 2004 Cancer immunotherapy: moving beyond current vaccines. Nat Med 10:909-915
78. Schumacher TN, Kantesaria DV, Heemels MT et al 1994 Peptide length and sequence specifi-city of the mouse TAP1/TAP2 translocator. J Exp Med 179:533-540
79. Segal BH, Wang XY, Dennis CG et al 2006 Heat shock proteins as vaccine adjuvants in infections and cancer. Drug Discov Today 11:534-540
80. Shen L, Rock KL 2006 Priming of T cells by exogenous antigen cross-presented on MHC class I molecules. Curr Opin Immunol 18:85-91
81. Shepherd JC, Schumacher TN, Ashton-Rickardt PG et al 1993 TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective. Cell 74:577-584
82. Singh-Jasuja H, Scherer HU, Hilf N et al 2000a The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor. Eur J Immunol 30:2211-2215
83. Singh-Jasuja H, Toes RE, Spee P et al 2000b Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis. J Exp Med 191:1965-1974
84. Srivastava PK 2000 Immunotherapy of human cancer: lessons from mice. Nat Immunol 1:363-366
85. Srivastava P 2002 Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu Rev Immunol 20:395-425
86. Srivastava P 2003 Hypothesis: controlled necrosis as a tool for immunotherapy of human cancer. Cancer Immun 3:4
87. Srivastava PK 2006 Therapeutic cancer vaccines. Curr Opin Immunol 18:201-205
88. Srivastava PK, Amato RJ 2001 Heat shock proteins: the 'Swiss Army Knife' vaccines against cancers and infectious agents. Vaccine 19:2590-2597
89. Srivastava PK, Old LJ 1988 Individually distinct transplantation antigens of chemically induced mouse tumors. Immunol Today 9:78-83
90. Strawbridge AB, Blum JS 2007 Autophagy in MHC class II antigen prpcessing. Curr Opin Immunol 19:87-92
91. Takenaka R, Yokota K, Ayada K et al 2004 Helicobacter pylori heat-shock protein 60 induces inflammatory responses through the Toll-like receptor-triggered pathway in cultured human gastric epithelial cells. Microbiology 150:3913-3922
92. Tang D, Khaleque AA, Jones ER et al 2005 Expression of heat shock proteins and HSP messenger ribonucleic acid in human prostate carcinoma in vitro and in tumors in vivo. Cell Stress Chaperones 10:46-59
93. Theriault JR, Mambula SS, Sawamura T, Stevenson MA, Calderwood SK 2005 Extracellular HSP70 binding to surface receptors present on antigen presenting cells and endothelial/ epithelial cells. FEBS Lett 579:1951-1960
94. Theriault JR, Adachi H, Calderwood SK 2006 Role of scavenger receptors in the binding and internalization of heat shock protein 70. J Immunol 177:8604-8611
95. Todryk S, Melcher AA, Hardwick N et al 1999 Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake. J Immunol 163:1398-1408
96. Topalian SL, Rivoltini L, Mancini M et al 1994 Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene. Proc Natl Acad Sci USA 91:9461-9465
97. Vabulas RM, Ahmad-Nejad P, Ghose S, Kirschning CJ, Issels RD, Wagner H 2002 HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J Biol Chem 277:15107-15112
98. Wilbanks SM, Chen L, Tsuruta H, Hodgson KO, McKay DB 1995 Solution small-angle X-ray scattering study of the molecular chaperone Hsc70 and its subfragments. Biochemistry 34:12095-12106
99. Wu SJ, Wang C 1999 Binding of heptapeptides or unfolded proteins to the chimeric C-terminal domains of 70kDa heat shock cognate protein. Eur J Biochem 259:449-455
100. Zanin-Zhorov A, Cahalon L, Tal G, Margalit R, Lider O, Cohen IR 2006 Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling. J Clin Invest 116:2022-2032
101. Zeng Y, Graner MW, Katsanis E 2006 Chaperone-rich cell lysates, immune activation and tumor vaccination. Cancer Immunol Immunother 55:329-338
102. Zou W 2006 Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 6:295-307